FDA-Drug2026-03-11Class IIPACKAGING DEFECT
Major Pharmaceuticals midodrine hydrochloride tablets recalled for defective blister packaging
What this means
Major Pharmaceuticals is recalling midodrine hydrochloride 5 mg tablets (Lot N02640, expiring 08/2027) because some blister packages are not properly sealed. Defective packaging could allow the medication to degrade or become contaminated. No injuries have been reported.
- Check if you have midodrine tablets from Lot N02640 with expiration date 08/2027
- Inspect the blister packaging for signs of damage or incomplete sealing
- Contact your pharmacist or doctor if you have this lot; do not use if packaging appears defective
- Do not dispose of medication in household trash; ask your pharmacy about safe disposal
The agency's original wording
Hazard
Defective container; inadequately sealed blister packaging.
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide US.
Affected count
8892 cartons
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0383-2026More The Harvard Drug recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.